no code implementations • 5 Mar 2024 • Hyeongwoo Kim, Seokhyun Moon, Wonho Zhung, Jaechang Lim, Woo Youn Kim
Our model's innovation lies in its capacity to design a bioisosteric replacement reflecting the compatibility with the surroundings of the modification site, facilitating the control of sophisticated properties like drug-likeness.
1 code implementation • 22 Aug 2020 • Seokhyun Moon, Wonho Zhung, Soojung Yang, Jaechang Lim, Woo Youn Kim
Recently, deep neural network (DNN)-based drug-target interaction (DTI) models were highlighted for their high accuracy with affordable computational costs.